For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

Published Date: 11 Mar 2024

Possible treatment for certain patients receiving brentuximab plus dacarbazine or nivolumab is discussed.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

2.

Housing aid linked to lower medical financial hardship among US renters with cancer

3.

Research suggests peer support may lower depression, stress among cancer patients in low-resource settings

4.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

5.

Spouses of Cancer Patients May Be at Increased Risk of Suicide


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot